Publications

Kroll, S. L., & Mayo, L. M. (2025). Chapter 5 - Anandamide and anxiety. In B. L. Foll (Ed.), Anandamide in Health and Disease (pp. 189-211): Academic Press.

Kroll, S. L., Meier, P., Mayo, L. M., Gertsch, J., & Quednow, B. B. (2024). Endocannabinoids and related lipids linked to social exclusion in individuals with chronic non-medical prescription opioid use. Neuropsychopharmacology, 49(10), 1630-1639. doi:10.1038/s41386-024-01881-8

Kroll, S. L., Hulka, L. M., Kexel, A. K., Vonmoos, M., Preller, K. H., Treyer, V., Ametamey, S. M., Baumgartner, M. R., Boost, C., Pahlisch, F., Rohleder, C., Leweke, F. M., & Quednow, B. B. (2023). Plasma endocannabinoids in cocaine dependence and their relation to cerebral metabotropic glutamate receptor 5 density. Transl Psychiatry, 13(1), 325. doi:10.1038/s41398-023-02628-7

Voegel, C. D., Kroll, S. L., Schmid, M. W., Kexel, A. K., Baumgartner, M. R., Kraemer, T., Binz, T. M., & Quednow, B. B. (2022). Alterations of Stress-Related Glucocorticoids and Endocannabinoids in Hair of Chronic Cocaine Users. Int J Neuropsychopharmacol, 25(3), 226-237. doi:10.1093/ijnp/pyab070

Kroll, S. L., Mayo, L. M., Asratian, A., Yngve, A., Perini, I., & Heilig, M. (2021). Negative self-evaluation induced by acute stress indexed using facial EMG. Psychoneuroendocrinology, 133, 105402. doi:10.1016/j.psyneuen.2021.105402

Kroll, S. L., Thayer, J. F., Williams, D. P., Pfabigan, D. M., Baumgartner, M. R., Lamm, C., & Quednow, B. B. (2021). Chronic non-medical prescription opioid use and empathy for pain: Does pain make the difference? Psychophysiology, 58(4), e13776. doi:10.1111/psyp.13776

Pfabigan, D. M., Rutgen, M., Kroll, S. L., Riecansky, I., & Lamm, C. (2021). The administration of the opioid buprenorphine decreases motivational error signals. Psychoneuroendocrinology, 128, 105199. doi:10.1016/j.psyneuen.2021.105199

Trostheim, M., Eikemo, M., Meir, R., Hansen, I., Paul, E., Kroll, S. L., Garland, E. L., & Leknes, S. (2020). Assessment of Anhedonia in Adults With and Without Mental Illness: A Systematic Review and Meta-analysis. JAMA Netw Open, 3(8), e2013233. doi:10.1001/jamanetworkopen.2020.13233

Kroll, S. L., Williams, D. P., Thoma, M., Staib, M., Binz, T. M., Baumgartner, M. R., Kirschbaum, C., Thayer, J. F., & Quednow, B. B. (2019). Non-medical prescription opioid users exhibit dysfunctional physiological stress responses to social rejection. Psychoneuroendocrinology, 100, 264-275. doi:10.1016/j.psyneuen.2018.09.023

Schote, A. B., Jager, K., Kroll, S. L., Vonmoos, M., Hulka, L. M., Preller, K. H., Meyer, J., Grunblatt, E., & Quednow, B. B. (2019). Glucocorticoid receptor gene variants and lower expression of NR3C1 are associated with cocaine use. Addict Biol, 24(4), 730-742. doi:10.1111/adb.12632

Kroll, S. L., Nikolic, E., Bieri, F., Soyka, M., Baumgartner, M. R., & Quednow, B. B. (2018). Cognitive and socio-cognitive functioning of chronic non-medical prescription opioid users. Psychopharmacology (Berl), 235(12), 3451-3464. doi:10.1007/s00213-018-5060-z

Kroll, S. L., Wunderli, M. D., Vonmoos, M., Hulka, L. M., Preller, K. H., Bosch, O. G., Baumgartner, M. R., & Quednow, B. B. (2018). Socio-cognitive functioning in stimulant polysubstance users. Drug Alcohol Depend, 190, 94-103. doi:10.1016/j.drugalcdep.2018.06.001